Intensive T2DM Tx Extends Complication-Free Survival

Share this content:
Intensive T2DM Tx Extends Complication-Free Survival
Intensive T2DM Tx Extends Complication-Free Survival

THURSDAY, Sept. 8, 2016 (HealthDay News) -- Early, intensified intervention in type 2 diabetes patients with microalbuminuria increases life span, with patients more likely free from severe complications, according to a study published online Aug. 16 in Diabetologia.

The new study included 160 Danish individuals who had type 2 diabetes and microalbuminuria. The participants were randomly assigned to conventional therapy or an intensified, multifactorial treatment that included behavioral and pharmacological intervention.

Thirty-eight intensive-therapy patients and 55 conventional-therapy patients died during follow-up of 21.2 years (hazard ratio, 0.55). The average survival was a median of 7.9 years longer for patients in the intensive-therapy group versus the conventional-therapy group. The median time to first cardiovascular event was 8.1 years longer in the intensive-therapy group, and the risk for all microvascular complications was decreased in the intensive-therapy group with the exception of peripheral neuropathy.

"Early, intensified intervention in type 2 diabetes patients with microalbuminuria with both target-driven pharmacological and behavioral actions increased life span. And, that extra life length is free from severe and feared complications," senior author Oluf Pedersen, M.D., a specialist in internal medicine and endocrinology for the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen in Denmark, told HealthDay.

Several authors disclosed financial ties to pharmaceutical companies, including Novo Nordisk, which funded the study.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Basivertebral Nerve Ablation Beneficial for Chronic Back Pain

Basivertebral Nerve Ablation Beneficial for Chronic Back Pain

Improvement in self-reported outcomes at three months in patients with chronic lumbar back pain

FDA Approves Trulance for Chronic Idiopathic Constipation

FDA Approves Trulance for Chronic Idiopathic Constipation

Drug designed to stimulate secretion of intestinal fluid

ECG Could Be Used As Password for E-Health Record Access

ECG Could Be Used As Password for E-Health ...

Researchers say heartbeat could serve as a secure 'password' for patient's electronic medical history

is free, fast, and customized just for you!

Already a member?

Sign In Now »